Sign In
Buy TRCK
$0.640
+0 (+0%)
At Close: Jun 03, 2026
ConnectM Retires Additional $1.9 Million Debt, Eliminating $31M in Total Liabilities to Date - On Track to be Debt-free by Q2 2025
08:00am, Thursday, 27'th Feb 2025
~ Currently operating at a $45M revenue run rate ~ ~ On Track to Achieve Operating Cash Flow Breakeven in Q1 2025 ~ MARLBOROUGH, Mass. , Feb. 27, 2025 /PRNewswire/ -- ConnectM Technology Solutions, In
Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
08:00am, Wednesday, 26'th Feb 2025
FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night driving impairment in keratorefractive patients with reduced mesopic vision Enro
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
07:30am, Wednesday, 26'th Feb 2025
Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) whose disease has progressed following treatment with platinum-bas
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
08:30am, Thursday, 20'th Feb 2025
– Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions – – Reflects positive preliminary Phase 2 Safety and Efficacy data reported to date – – May
B2Gold Reports Q4 and Full Year 2024 Results; Achieved 2024 Total Gold Production and Consolidated Cost Guidance; Goose Project Remains On Track for First Gold in Q2 2025 and Total Capital Estimate Remains at C$1,540 Million; Q1 2025 Dividend of US$0.02 per Share Declared
06:00pm, Wednesday, 19'th Feb 2025
VANCOUVER, British Columbia, Feb. 19, 2025 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) announces its operational and financial results
Home Builder Stocks Are on Track for Worst February in 5 Years. What's Dragging Them Down.
04:54pm, Wednesday, 19'th Feb 2025
High construction costs, rising mortgage rates, and looming tariffs are pressuring the stocks.
American Water Reports 2024 Results on Track; Affirms Long-Term Growth Targets; CEO Hardwick to Retire in May, Griffith to Assume CEO Role
04:31pm, Wednesday, 19'th Feb 2025
CAMDEN, N.J.--(BUSINESS WIRE)--American Water Works Company, Inc. (NYSE: AWK) today reported earnings of $1.22 per share for the fourth quarter 2024 compared to $0.88 per share in 2023, and full year
Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors
08:04am, Wednesday, 19'th Feb 2025
Life sciences investment firm Deep Track Capital is launching a board fight at Dynavax Technologies , pressing for new directors to prioritize the development of the company's hepatitis B vaccine inst
Fast Retailing's Next Development Phase Likely To Continue An Impressive Growth Track Record
03:04am, Wednesday, 19'th Feb 2025
Fast Retailing's recent results have been mixed, with weather impacting sales in Japan and weak consumer spending hitting results in China, while other markets have been quite strong. Weather has been
SAN FRANCISCO and SUZHOU, China , Feb. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercial
Gold Price Forecast: On Track for Record High Closing Price
04:44pm, Thursday, 13'th Feb 2025
A bullish Marubozu pattern confirms strength in gold, setting up the metal for higher targets, with resistance levels aligning at $2,981, $2,982, and possibly $3,000.
S&P 500 Remains on Track for 6400-6500
03:20pm, Thursday, 13'th Feb 2025
If the bulls hold above last Monday's low at $6003 and especially the January 13 low at $5773, they remain in charge, and a rally to $6365ish is underway.
NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer's Disease
08:00am, Wednesday, 12'th Feb 2025
The Fast Track designation accelerates troculeucel's path to U.S. FDA submission for the treatment of patients with moderate Alzheimer's disease. NKGen will benefit from increased FDA interactions, en
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
07:30am, Wednesday, 12'th Feb 2025
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatmen
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
08:30am, Monday, 10'th Feb 2025
February 10, 2025 Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a therapeutic alternative with the potential to delay or prevent
